Olmesartan Medoxomil/Amlodipine Accord Healthcare (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Amlodipine Accord Healthcare, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adults. It combines olmesartan medoxil with amlodipine, a calcium‑channel blocker, to provide complementary blood‑pressure lowering effects.

GNH USA supplies Olmesartan Medoxomil/Amlodipine Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan Medoxil/Amlodipine is indicated for hypertension, acting on the renin‑angiotensin system and vascular smooth‑muscle tone. - Hypertension: improves blood‑pressure control when monotherapy is insufficient. - Hypertension with isolated systolic elevation: provides additional vasodilation to lower systolic pressure. - Hypertensive patients at high cardiovascular risk: contributes to reduction of stroke and myocardial‑infarction risk when combined with lifestyle measures.

Adverse reactions may occur with any antihypertensive regimen and should be monitored during therapy.

Common Side Effects: - Dizziness or light‑headedness - Headache - Peripheral edema - Flushing - Fatigue - Nasal congestion

Serious or Rare Side Effects: - Angio‑edema involving the face, lips or tongue - Severe hypotension - Acute kidney injury - Elevated liver enzymes - Heart block or severe bradycardia - Allergic skin reactions such as Stevens‑Johnson syndrome

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters. - Renal function: evaluate creatinine clearance before starting and periodically thereafter. - Hepatic function: check liver enzymes in patients with known liver disease. - Electrolytes: monitor potassium and sodium levels, especially if combined with diuretics. - Pregnancy: avoid use; drug is contraindicated in the second and third trimesters. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Olmesartan Medoxil/Amlodipine may interact with several concomitant medicines; clinical judgement is required.

Major Interactions (Avoid): - Potassium‑rich supplements or potassium‑sparing diuretics: risk of hyper‑kalemia. - Dual renin‑angiotensin system blockade (e.g., ACE inhibitor or another ARB): increased risk of renal impairment. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): may raise amlodipine levels.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect and affect renal function. - Diuretics: additive blood‑pressure lowering may require dose adjustment. - Lithium: may increase serum lithium concentrations. - Alcohol: can enhance dizziness and hypotensive effects. - Antacids containing aluminium or magnesium: may affect absorption of olmesartan.